Literature DB >> 29062775

Evaluating role of bone marrow-derived stem cells in dry age-related macular degeneration using multifocal electroretinogram and fundus autofluorescence imaging.

Atul Kumar1, Neha Midha1, Sujata Mohanty2, Annu Chohan1, Tulika Seth3, Varun Gogia1, Shikha Gupta1.   

Abstract

AIM: To evaluate the role of bone marrow-derived stem cells in the treatment of advanced dry age-related macular degeneration (AMD) using multifocal electroretinogram (mf-ERG) and fundus autofluorescence imaging.
METHODS: Thirty patients (60 eyes) with bilateral central geographic atrophy (GA) were recruited. Worse eye of each patient received autologous bone marrow-derived hematopoietic stem cells (BM-HSCs) (group 1) and the fellow eye with better visual acuity served as control (group 2). The effect of stem cell therapy was determined in terms of visual acuity, amplitude and implicit time in mf-ERG and size of GA on fundus autofluorescence imaging. These tests were performed at presentation and first, third and sixth month follow up. Adverse events (if any) were also monitored.
RESULTS: At 6mo follow-up there was no statistically significant improvement in median logMAR best corrected visual acuity (BCVA) in either group. Mf-ERG revealed significant improvement in amplitude and implicit time in the intervention group. A significant decrease was also noted in greatest linear dimension (GLD) of GA in the eyes receiving stem cells [6.78±2.60 mm at baseline to 6.56±2.59 mm at 6mo (P=0.021)]. However, no such improvement was noted in the control group.
CONCLUSION: Electrophysiological and anatomical improvement in the intervention group sheds light on the therapeutic role of BM-HSCs. Further studies are required to determine the stage of disease at which the maximal benefit can be achieved and to standardize the dose and frequency of stem cell injection.

Entities:  

Keywords:  dry age-related macular degeneration; fundus autofluorescence imaging; multifocal electroretinogram; stem cells

Year:  2017        PMID: 29062775      PMCID: PMC5638977          DOI: 10.18240/ijo.2017.10.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  34 in total

1.  Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice.

Authors:  M A Eglitis; E Mezey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 2.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

3.  Bone marrow as a source of endothelial cells and NeuN-expressing cells After stroke.

Authors:  David C Hess; William D Hill; Angeline Martin-Studdard; James Carroll; Joanna Brailer; Jo Carothers
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  Chromosomal number aberrations and transformation in adult mouse retinal stem cells in vitro.

Authors:  Meta Djojosubroto; Frederic Bollotte; Pratyaksha Wirapati; Freddy Radtke; Ivan Stamenkovic; Yvan Arsenijevic
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

Review 6.  Stem cell therapy and the retina.

Authors:  R E MacLaren; R A Pearson
Journal:  Eye (Lond)       Date:  2007-10       Impact factor: 3.775

7.  Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina.

Authors:  Minoru Tomita; Yasushi Adachi; Haruhiko Yamada; Kanji Takahashi; Katsuji Kiuchi; Haruki Oyaizu; Kazuya Ikebukuro; Hiroyuki Kaneda; Miyo Matsumura; Susumu Ikehara
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

8.  Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Amanda A Honeycutt; Sarah B Lesesne; Jinan Saaddine
Journal:  Arch Ophthalmol       Date:  2009-04

9.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Authors: 
Journal:  JAMA       Date:  2013-05-15       Impact factor: 56.272

10.  Density gradient centrifugation compromises bone marrow mononuclear cell yield.

Authors:  Claudia Pösel; Karoline Möller; Wenke Fröhlich; Isabell Schulz; Johannes Boltze; Daniel-Christoph Wagner
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

View more
  1 in total

1.  Commentary: Learning curve of a trained vitreo-retinal surgeon in sub-retinal injections in a rat model: Implications for future clinical trials.

Authors:  Atul Kumar; Divya Agarwal
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.